Literature DB >> 10586902

Common occurrence of concurrent infections by multiple dengue virus serotypes.

M A Loroño-Pino1, C B Cropp, J A Farfán, A V Vorndam, E M Rodríguez-Angulo, E P Rosado-Paredes, L F Flores-Flores, B J Beaty, D J Gubler.   

Abstract

The co-circulation of all 4 dengue virus serotypes in the same community, common since the 1950s in Southeast Asia, has now become a frequent occurrence in many Caribbean Islands, Mexico, and Central and South America in the past 20 years. As a consequence, the frequency of concurrent infections would be expected to increase in these areas. To assess this, using state of the art technology, we screened viremic serum samples and mosquitoes inoculated with serum samples collected during epidemics involving multiple dengue virus serotypes in Indonesia, Mexico, and Puerto Rico for virus isolation. Of 292 samples tested, 16 (5.5%) were found to contain 2 or more dengue viruses by an indirect immunofluorescence test and/or the reverse transcriptase-polymerase chain reaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586902     DOI: 10.4269/ajtmh.1999.61.725

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  50 in total

1.  Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA.

Authors:  W K Wang; C N Lee; C L Kao; Y L Lin; C C King
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Cross-Immunity and Community Structure of a Multiple-Strain Pathogen in the Tick Vector.

Authors:  Jonas Durand; Maxime Jacquet; Lye Paillard; Olivier Rais; Lise Gern; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  Effect of sequential exposure on infection and dissemination rates for West Nile and St. Louis encephalitis viruses in Culex quinquefasciatus.

Authors:  Kendra Pesko; Christopher N Mores
Journal:  Vector Borne Zoonotic Dis       Date:  2009-06       Impact factor: 2.133

4.  Stability and loss of a virus resistance phenotype over time in transgenic mosquitoes harbouring an antiviral effector gene.

Authors:  A W E Franz; I Sanchez-Vargas; J Piper; M R Smith; C C H Khoo; A A James; K E Olson
Journal:  Insect Mol Biol       Date:  2009-10       Impact factor: 3.585

Review 5.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

Review 6.  Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

Authors:  Jorge E Osorio; Claire Y-H Huang; Richard M Kinney; Dan T Stinchcomb
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

7.  Spatial-Temporal Co-Circulation of Dengue Virus 1, 2, 3, and 4 Associated with Coinfection Cases in a Hyperendemic Area of Brazil: A 4-Week Survey.

Authors:  Elisa H P Andrade; Leandra B Figueiredo; Ana P P Vilela; Júlio C C Rosa; Jaquelline G Oliveira; Hassan M Zibaoui; Valdelaine E M Araújo; Daniela P J Miranda; Paulo C P Ferreira; Jonatas S Abrahão; Erna G Kroon
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

8.  Density-dependent competitive suppression of sylvatic dengue virus by endemic dengue virus in cultured mosquito cells.

Authors:  Kim M Pepin; Kathryn A Hanley
Journal:  Vector Borne Zoonotic Dis       Date:  2008-12       Impact factor: 2.133

Review 9.  Microevolution and virulence of dengue viruses.

Authors:  Rebeca Rico-Hesse
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

10.  Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016.

Authors:  S Viridiana Laredo-Tiscareño; Javier A Garza-Hernandez; Ma Isabel Salazar; Erick J De Luna-Santillana; Chandra S Tangudu; Rosa C Cetina-Trejo; Gloria L Doria-Cobos; Santos Daniel Carmona-Aguirre; Julian E Garcia-Rejon; Carlos Machain-Williams; Bradley J Blitvich; Mario Alberto Rodríguez Pérez
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.